: FDA approves BioMarin’s gene therapy drug for hemophilia
BioMarin Pharmaceutical Inc. BMRN received Food and Drug Administration approval of its gene therapy Roctavian to treat hemophilia A, the agency said late Thursday. The...
Hepatitis C cure is not reaching overwhelming majority of patients due to financial barriers
Hepatitis C is often referred to as the silent killer because the initial infection has few to no symptoms.
Overstock.com shares spike 20% after company announces Bed Bath & Beyond website rebrand
Overstock CEO Jonathan Johnson said the Bed Bath & Beyond name better aligns with the company's products and maintains good brand awareness.
Southwest pilots’ union lays groundwork for potential strike with labor talks at an impasse
Southwest's pilots' union is seeking to be released from federal mediation, a step toward a potential strike.
Former Pfizer employee charged with insider trading on unreleased Covid pill data
The DOJ said the former employee and his close friend sold their Pfizer call options at "significant profits" totaling more than $350,000.
Little-known NJ baby retailer tentatively wins rights to Buy Buy Baby’s IP
Little-known baby retailer Dream on Me Industries has tentatively won the rights to Buy Buy Baby ahead of an auction for all of the chain's...
These retailers will take over Bed Bath & Beyond’s ‘top-notch’ store leases
Burlington Stores is set to take over 50 former Bed Bath & Beyond locations after the home goods retailer auctioned its leases.
House hunting is already tough. Guess what? It’s about to get harder
In the last week of June, the number of homes for sale fell below year-ago levels for the first time in 59 weeks.
Nike posts first earnings miss in three years as lower margins hit sports apparel giant
Nike missed on earnings for the first time in three years after promotions and freight costs pressured the sneaker giant's margins.